April 8, 2020 / By Madeline Farber | Fox News
In the rush to find a viable treatment option for COVID-19 patients, scientists at the University of North Carolina at Chapel Hill hope to have found at least one solution.
Researchers at the university’s Gillings School of Global Public Health developed a potential antiviral treatment they claim “shows promise in reducing lung damage” in those infected with the novel virus.
The antiviral treatment, EIDD-2801, was tested in mice infected with both MERS-CoV and SARS-CoV-2, the virus that causes COVID-19. The drug was also tested on cultured human lung cells infected with SARS-CoV-2, according to a news release from UNC at Chapel Hill.
